rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
24
|
pubmed:dateCreated |
1991-12-17
|
pubmed:abstractText |
Surfactant-replacement therapy is now recognized as a life-saving and safe intervention in small premature infants, but there is little evidence concerning its risks and benefits in larger premature infants.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
325
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1696-703
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1944470-Birth Weight,
pubmed-meshheading:1944470-Bronchopulmonary Dysplasia,
pubmed-meshheading:1944470-Child,
pubmed-meshheading:1944470-Drug Combinations,
pubmed-meshheading:1944470-Fatty Alcohols,
pubmed-meshheading:1944470-Female,
pubmed-meshheading:1944470-Follow-Up Studies,
pubmed-meshheading:1944470-Humans,
pubmed-meshheading:1944470-Infant, Newborn,
pubmed-meshheading:1944470-Infant, Premature, Diseases,
pubmed-meshheading:1944470-Male,
pubmed-meshheading:1944470-Phosphorylcholine,
pubmed-meshheading:1944470-Polyethylene Glycols,
pubmed-meshheading:1944470-Pulmonary Surfactants,
pubmed-meshheading:1944470-Respiratory Distress Syndrome, Newborn,
pubmed-meshheading:1944470-Ventilator Weaning
|
pubmed:year |
1991
|
pubmed:articleTitle |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
|
pubmed:affiliation |
Clinical Research Division, Wellcome Research Laboratories, Research Triangle Park, NC 27709.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Controlled Clinical Trial,
Multicenter Study
|